---
title: Selenium and Coenzyme Q10 Intervention Prevents Telomere Attrition, with Association
  to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial
type: pub
encoding: UTF-8

---
<h1>Publikasjon</h1>
<article id="csl-bib-container-BCWYNDU7" class="csl-bib-container">
  <div class="csl-bib-body"> <div class="csl-entry">Opstad, T. B., Alexander, J., Aaseth, J., Larsson, A., Seljeflot, I., &#38; Alehagen, U. (2022). Selenium and Coenzyme Q10 Intervention Prevents Telomere Attrition, with Association to Reduced Cardiovascular Mortality-Sub-Study of a Randomized Clinical Trial. <i>Nutrients</i>, <i>14</i>(16). <a href="https://doi.org/10.3390/nu14163346">https://doi.org/10.3390/nu14163346</a></div> </div>
  <div class="csl-bib-buttons">
    <a href="#taxonomy-article-BCWYNDU7" alt="archive" class="csl-bib-button">Arkiv</a>
    <a href="https://app.cristin.no/results/show.jsf?id=2050223" alt="Cristin" class="csl-bib-button">Cristin</a>
    <a href="http://zotero.org/groups/5881554/items/BCWYNDU7" alt="Zotero" class="csl-bib-button">Zotero</a>
    <a href="#keywords-article-BCWYNDU7" alt="keywords" class="csl-bib-button">Emneord</a>
    <a href="#about-article-BCWYNDU7" alt="about_pub" class="csl-bib-button">Om</a>
    <a href="#sdg-article-BCWYNDU7" alt="sdg" class="csl-bib-button">Berekraftsmål</a>
    <a href="https://www.mdpi.com/2072-6643/14/16/3346/pdf?version=1661241366" alt="Unpaywall" class="csl-bib-button">Unpaywall</a>
    <a href="https://www.mdpi.com/2072-6643/14/16/3346/pdf?version=1661241366" alt="EZproxy" class="csl-bib-button">EZproxy</a>
  </div>
  <div id="csl-bib-meta-container-BCWYNDU7"></div>
</article>
<div id="csl-bib-meta-BCWYNDU7" class="csl-bib-meta">
  <article id="about-article-BCWYNDU7" class="about_pub-article">
    <h1>Om</h1>
    Opstad et al. gjennomførte ein studie for å undersøke om inntak av selen- og koenzym Q10-tilskot kunne bidra til å forhindre forkorting av telomerar, som er beskyttande endar på kromosom knytt til aldring og hjartesjukdom. Dei studerte 118 eldre vaksne i Sverige med låge selen-nivå over ein periode på 42 månader. Studien fann at dei som tok tilskota opplevde mindre telomerforkorting samanlikna med dei som tok placebo. Viktigast var at personar med lengre telomerar etter tilskotet var mindre sannsynleg å døy av hjarterelaterte problem. Dette tyder på at å oppretthalde telomerlengde gjennom desse tilskota kan vere gunstig for hjartes helse og levetid.
  </article>
  <article id="keywords-article-BCWYNDU7" class="keywords-article">
    <h1>Emneord</h1>
    Selen, Koenzym Q10, Telomerforkorting, Kardiovaskulær dødelegheit, Leukocytt-telomerlengde
  </article>
  <article id="abstract-article-BCWYNDU7" class="abstract-article">
    <h1>Samandrag</h1>
    Abstract 
Short telomeres have been associated with ageing and cardiovascular disease. The influence on leukocyte telomere length (LTL) of long-term intervention with combined selenium and coenzyme Q10 is unknown. Our aim was to determine whether 42 months of selenium and coenzyme Q10 supplementation prevented telomere attrition and further cardiovascular mortality. The investigation is an explorative sub-study of a double-blind, placebo-controlled, randomized trial. Swedish citizens low in selenium (n = 118), aged 70–80 years, were included. Intervention time was 4 years, with 10 years’ follow-up time. LTL was relatively quantified with PCR at baseline and after 42 months. At baseline, LTL (SD) was 0.954 (0.260) in the active treatment group and 1.018 (0.317) in the placebo group (p = 0.23). At 42 months, less shortening of LTL was observed after active treatment compared with placebo (+0.019 vs. −0.129, respectively, p = 0.02), with a significant difference in change basing the analysis on individual changes in LTL (p &lt; 0.001). Subjects suffering future death presented with significantly shorter LTL at 42 months than survivors [0.791 (0.190) vs. 0.941 (0.279), p = 0.01], with a significant difference in change of LTL according to cardiovascular mortality and survival (p = 0.03). To conclude, preservation of LTL after selenium and coenzyme Q10 supplementation associated with reduced cardiovascular mortality.
  </article>
  <article id="sdg-article-BCWYNDU7" class="sdg-article">
    <h1>Berekraftsmål</h1>
    <div class="sdg-container"><div id="sdg3" class="sdg">
        <img src="{{< params subfolder >}}images/sdg/sdg03_nn.png" class="image" alt="SDG 3">
        <div class="sdg-overlay">
          <a href="{{< params subfolder >}}nn/archive/?sdg=3#archive" class="sdg-publication-count"><span>1358</span> publikasjonar</a>
          <p><a href="https://fn.no/om-fn/fns-baerekraftsmaal/god-helse-og-livskvalitet?lang=nno-NO" class="sdg-read-more">Les meir</a></p>
        </div>
      </div></div>
  </article>
  <article id="taxonomy-article-BCWYNDU7" class="taxonomy-article">
    <h1>Arkiv</h1>
    <ul>
      <li><a href="{{< params subfolder >}}nn/archive/?key=3DCRN523">Universitetet i Innlandet</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=IDKFS3MX">Fakultet for helse- og sosialvitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=GTV4ECMZ">Institutt for helse- og sykepleievitenskap</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=558P36BB">2022</a></li>
      <li><a href="{{< params subfolder >}}nn/archive/?key=KKN33L7H">September</a></li>
    </ul>
  </article>
</div>
